April 15 -17, 2025
Hyatt Regency | Indianapolis, IndianaFollow us for updates & more information!
Human Papillomavirus (HPV) is known to cause six types of cancers in all genders. Despite availability of a vaccine, the U.S. continues to see an alarming rate of HPV transmission and HPV-related cancers. Professionals at the national, regional, state, and local levels are working tirelessly on evidence-based practices and want to collaborate with others to increase prevention, early detection, and treatment of HPV-related diseases.
The goal of this inaugural conference is to invite all U.S. professionals working in the HPV space to come together in an effort to learn and share. While many conferences strive to include HPV as one of many topics, this conference seeks to make HPV the main topic. Attendees will enjoy learning and connecting with peers, while forming new ideas and partnerships to make their own HPV-related efforts stronger.
Together, we can strive to eliminate HPV-related diseases and cancers in the U.S.
Hosted By
National Planning Committee
These partners are working to make the National HPV Conference a more comprehensive and valuable experience for all participants.
The national planning committee consists of members from:
- American Cancer Society
- American Cancer Society National Roundtable on Cervical Cancer
- American Cancer Society National HPV Vaccination Roundtable
- Centers for Disease Control and Prevention
- Global Initiative Against HPV and Cervical Cancer
- Indiana Immunization Coalition
- National Cancer Institute
- National Council of Negro Women
- Recurrent Respiratory Papillomatosis Foundation
- St. Jude Children’s Research Hospital
- Unity Consortium
About the Conference
Expected Outcomes
The National HPV Conference was established to create a venue for networking, dissemination of best practices, resource sharing, and cross collaboration in a way never done before in the United States. We are excited for the opportunity to have HPV champions across key sectors convene together to advance HPV prevention efforts nationally. This inaugural conference will allow participants to:
- Connect with like-minded people from across the country
- Share and learn from others’ experiences
- Stimulate new ideas
- Identify ways to collaborate locally and across state lines
- Develop actionable work plans to implement at home
- Unite in efforts to achieve our central goal of eliminating HPV infections in the U.S.
Intended Audience
The intended audience for this conference is wide-reaching by design. The goal of the conference is to convene professionals who work in many different areas of the HPV continuum in an effort to create partnerships and collaboration. During this inaugural conference, we anticipate 350-500 attendees. The gathering is specifically aimed at professionals in the U.S. who work in and with the public regarding HPV. Some examples of these professionals are:
Guest Speakers
Keynote Speaker
Robin Vanderpool, DrPH
Robin C. Vanderpool, Dr.P.H., is chief of the Health Communication and Informatics Research Branch (HCIRB) in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI). Dr. Vanderpool’s scientific background includes both formative and interventional research on HPV vaccination, cancer screening, cancer survivorship, implementation science, and rural cancer control.
Keynote Speaker
Georgina Peacock, MD, MPH
Dr. Georgina Peacock is the Director of the Immunization Services Division (ISD) in the National Center for Immunization and Respiratory Diseases (NCIRD) at CDC. In this role, Dr. Peacock oversees support of immunization programs, provider and public education, and evaluation and research. During her 15 years with CDC, Dr. Peacock has been dedicated to developing and implementing public health programs that support children and adults in underserved populations to lead healthy lives.
HPV Survivor Panelist
Tamika Felder, Survivor
Diagnosed with cancer at 25 while working as an award-winning television producer in Washington, D.C., Tamika has spent the rest of her life proving that triumph over tragedy is entirely possible. A cancer survivor, award-winning women’s health advocate, and Chief Visionary at Cervivor – a nonprofit dedicated to cervical cancer advocacy and support – Tamika also has a mission to eradicate cancer and shine a spotlight on the patient voice in healthcare.
HPV Survivor Panelist
Jason Mendelsohn, Survivor
Jason, a stage IV HPV-attributed tonsil cancer survivor, made the decision to share his cancer story publicly so that others could learn about HPV oropharyngeal cancer, oral cancer screening, and the HPV vaccine. First diagnosed in May 2014, he underwent a radical tonsillectomy and neck dissection, followed by seven weeks of chemo, radiation and a feeding tube. He launched SupermanHPV.com in September 2017, to inspire, educate and encourage others diagnosed with HPV-attributed oropharyngeal cancer.
HPV Survivor Panelist
Lillian Kreppel, Survivor
Lillian Kreppel knew she had HPV because like many women, she’s had an abnormal Pap. Always diligent about preventive checkups, she saw two doctors when she began having suspicious symptoms and was diagnosed with Stage II anal cancer at 53. After successful treatment that she credits to superb medical care and a rock-solid circle of friends, Lillian dove headfirst into bringing this rare cancer into the spotlight. She serves as a patient ambassador for the Anal Cancer Foundation.
HPV Survivor Panelist
Kim McClellan, Survivor
In 1971 at age five, Kim was diagnosed with Recurrent Respiratory Papillomatosis (RRP), a rare disease that left her barely able to speak or struggling to even breathe. After decades of surgery after surgery, and ultimately a tracheostomy, Kim regained her voice. Now as the President of the Recurrent Respiratory Papillomatosis Foundation, a patient advocacy organization, she is using her voice to fight for recognition, treatment options, and hope for all RRP patients and their families
Focus Tracks
Vaccination and Prevention
This track will focus on measures to prevent HPV infection, including education and awareness, advocacy, policy, vaccination, sexual health, health disparities, and more. Speakers will be encouraged to share programs, practices, and materials that have been successful in the realm of HPV prevention. Participants will leave with new ideas and actionable items.
Research and Best Practices
This track invites area experts and researchers to present findings directly related to public-facing HPV care and prevention. Presentations should not be overly technical, but should privilege projects that include evaluation data, consensus statements, or similar approaches to establishing best practices. Applicable topics might include health equity, best practices, health communication, dissemination, or implementation science.
Cancer Screening and Treatment
This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.
Public Health and Collaboration
This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication.
Day 1
Day 2
Day 3
Call for Abstracts
Abstract submission closed on October 15th at 8 PM ET.
Additional posters may be accepted in early Spring if space allows. Sign up for updates
- Call for abstracts submissions open: June 15, 2024.
- Deadline for abstract submission: September 15, 2024 October 15, 2024 at 8pm ET.
- Deadline for reviewers to complete abstract reviews: October 15, 2024 November 15, 2024 at 8pm ET.
- Program decisions will go out on or before November 15, 2024 December 20, 2024.
Registration
Regular Ticket: Early $400 / Regular $500 / Late $600
Student Ticket: Early $200 / Regular $250
Early: September 6 – January 15 | Regular: January 16 – March 31 | Late: April 1 – Conference
Sponsor or Exhibit
View the prospectus here
Thank you for your sponsorship consideration. This is your opportunity to engage with a targeted audience of professionals eager to make a difference in the HPV arena. Sponsorship not only provides exposure and networking for your organization, but also provides the financial support necessary to offer this conference at a reasonable, accessible price for all attendees.
CONFERENCE LOCATION
Hyatt Regency Indianapolis | 1 S. Capitol Avenue, Indianapolis, IN 46204
The hotel is located in downtown Indianapolis, less than 15 miles from the IND airport. Indiana is known as the “Crossroads of America” due to its central location and ease of accessibility by car or airplane. Downtown Indianapolis features an exciting assortment of restaurants, museums, and cultural attractions, making it a prime conference destination. Find out more about Indianapolis at www.visitindy.com
Use the links below to reserve your room
Government per diem rates are for qualified government employees. ID may be required at check-in.
Conference registration and hotel reservations are separate. Make sure to register for the conference here.